NIOX Group Investor Relations Material
Latest events
Trading Update
8 Jul, 2025
Trading Update
16 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NIOX Group Plc
Access all reports
NIOX Group Plc is a medical device company focused on the diagnosis and management of respiratory diseases, with a particular emphasis on asthma. The company's flagship product, NIOX VERO, is a non-invasive, point-of-care device designed for the measurement of fractional exhaled nitric oxide, which is a biomarker for airway inflammation in asthma patients. This device aids healthcare professionals in diagnosing and managing asthma by providing precise FeNO measurements. The company is headquartered in Oxford, United Kingdom, and its shares are listed on the London Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NIOX
Country
🇬🇧 United Kingdom